These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25183567)

  • 1. Adverse events of haloperidol for the treatment of delirium in critically ill children.
    Slooff VD; Spaans E; van Puijenbroek E; Jessurun N; van Beusekom BS; de Hoog M; Tibboel D; de Wildt SN
    Intensive Care Med; 2014 Oct; 40(10):1602-3. PubMed ID: 25183567
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring Haloperidol Plasma Concentration and Associated Adverse Events in Critically Ill Children With Delirium: First Results of a Clinical Protocol Aimed to Monitor Efficacy and Safety.
    Slooff VD; van den Dungen DK; van Beusekom BS; Jessurun N; Ista E; Tibboel D; de Wildt SN
    Pediatr Crit Care Med; 2018 Feb; 19(2):e112-e119. PubMed ID: 29239979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delirium in critically ill children in a paediatric intensive care unit].
    Schieveld JN; Leroy PL; Leentjens AF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1545-8. PubMed ID: 16886689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.
    Duprey MS; Devlin JW; van der Hoeven JG; Pickkers P; Briesacher BA; Saczynski JS; Griffith JL; van den Boogaard M
    Crit Care Med; 2021 Aug; 49(8):1303-1311. PubMed ID: 33861548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant delirium in pediatric critical care settings.
    Silver GH; Kearney JA; Kutko MC; Bartell AS
    Am J Psychiatry; 2010 Oct; 167(10):1172-7. PubMed ID: 20889664
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of haloperidol in the agitated, critically ill pediatric patient with burns.
    Brown RL; Henke A; Greenhalgh DG; Warden GD
    J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol for the management of delirium in adult intensive care unit patients: A systematic review and meta-analysis of randomized controlled trials.
    Zayed Y; Barbarawi M; Kheiri B; Banifadel M; Haykal T; Chahine A; Rashdan L; Aburahma A; Bachuwa G; Seedahmed E
    J Crit Care; 2019 Apr; 50():280-286. PubMed ID: 30665181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
    Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW;
    N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to the comment by Skrobik et al.
    de Rooij S; de Jonge E
    Intensive Care Med; 2004 Jul; 30(7):1500; author reply 1501. PubMed ID: 15160237
    [No Abstract]   [Full Text] [Related]  

  • 12. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitation in the critically ill patient: a marker of health or a plea for treatment?
    Schweickert W; Hall JB
    Crit Care Med; 2005 Jan; 33(1):263-5. PubMed ID: 15644697
    [No Abstract]   [Full Text] [Related]  

  • 14. Haloperidol for Treatment of ICU Delirium - Progress or Setback?
    Marcantonio ER
    N Engl J Med; 2022 Dec; 387(26):2464-2465. PubMed ID: 36577104
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit.
    Schieveld JN; Leroy PL; van Os J; Nicolai J; Vos GD; Leentjens AF
    Intensive Care Med; 2007 Jun; 33(6):1033-40. PubMed ID: 17457571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial.
    van den Boogaard M; Slooter AJC; Brüggemann RJM; Schoonhoven L; Beishuizen A; Vermeijden JW; Pretorius D; de Koning J; Simons KS; Dennesen PJW; Van der Voort PHJ; Houterman S; van der Hoeven JG; Pickkers P; ; van der Woude MCE; Besselink A; Hofstra LS; Spronk PE; van den Bergh W; Donker DW; Fuchs M; Karakus A; Koeman M; van Duijnhoven M; Hannink G
    JAMA; 2018 Feb; 319(7):680-690. PubMed ID: 29466591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine vs haloperidol: treating delirium in a critical care setting.
    Skrobik YK; Bergeron N; Dumont M; Gottfried SB
    Intensive Care Med; 2004 Mar; 30(3):444-9. PubMed ID: 14685663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk for delirium: a systematic review of quantitative evidence protocol.
    Santos E; Cardoso D; Apóstolo J; Neves H; Cunha M; Rodrigues M
    JBI Database System Rev Implement Rep; 2015 Aug; 13(7):83-92. PubMed ID: 26455848
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic Haloperidol Effects on Long-term Quality of Life in Critically Ill Patients at High Risk for Delirium: Results of the REDUCE Study.
    Rood PJT; Zegers M; Slooter AJC; Beishuizen A; Simons KS; van der Voort PHJ; van der Woude MCE; Spronk PE; van der Hoeven JG; Pickkers P; van den Boogaard M
    Anesthesiology; 2019 Aug; 131(2):328-335. PubMed ID: 31246603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol dosing strategies in the treatment of delirium in the critically ill.
    Wang EH; Mabasa VH; Loh GW; Ensom MH
    Neurocrit Care; 2012 Feb; 16(1):170-83. PubMed ID: 22038577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.